Related Experiment Videos
Amycolatopsis alba sp. nov., isolated from soil
1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
International Journal of Systematic Bacteriology
|October 1, 1993
Summary
A novel soil bacterium, Amycolatopsis alba, produces a new vancomycin-related glycopeptide antibiotic. This discovery expands the known repertoire of antibiotic-producing microorganisms and offers potential for new therapeutic agents.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Taxonomy
Background:
- Soil microorganisms are a rich source of novel bioactive compounds.
- Glycopeptide antibiotics, like vancomycin, are crucial for treating bacterial infections.
- The need for new antibiotics is driven by increasing antimicrobial resistance.
Purpose of the Study:
- To isolate and characterize a new antibiotic-producing microorganism from soil.
- To determine the taxonomic position of the novel isolate.
- To identify and describe the novel glycopeptide antibiotic produced.
Main Methods:
- Isolation of microorganisms from soil samples.
- Cultivation and morphological characterization of the isolate.
- Fatty acid analysis, cell wall composition, sugar patterns, phospholipid analysis, and menaquinone analysis for taxonomic classification.
- Chemical analysis to characterize the produced antibiotic.
Main Results:
- A new Amycolatopsis species, named Amycolatopsis alba (type strain A83850), was identified.
- The organism produces a novel glycopeptide antibiotic structurally related to vancomycin.
- Detailed chemotaxonomic data (cell wall type IV, sugar pattern A, phospholipid PII, MK-9(H4) major menaquinone) support the new species designation.
Conclusions:
- Amycolatopsis alba represents a new species of antibiotic-producing actinomycetes.
- The discovery of this novel glycopeptide antibiotic offers potential for new therapeutic interventions.
- This finding underscores the importance of exploring microbial diversity for novel drug discovery.